The most impactful recent advance is the formal adoption of a two-phase induction-then-maintenance protocol, replacing the historical pattern of treating each flare in isolation. The induction (stabilization) phase uses topical antimicrobial-antifungal-glucocorticoid combinations to achieve remission, followed by a proactive maintenance phase with topical hydrocortisone aceponate (HCA) to prevent relapse — a framework now supported by clinical outcome data.Journal of the…+1 In one protocol, the stabilization phase used a ciprofloxacin-clotrimazole-betamethasone suspension, followed by topical HCA for 90 days in the proactive phase; most dogs showed no recurrence of otitis throughout the remaining observation period, with marked reduction in both cytological and clinical scores.BMC Veterinary…
The primary-secondary-predisposing-perpetuating (PSPP) framework has been reaffirmed as non-negotiable: all recurrent otitis in dogs is secondary, and treating the infection without diagnosing the primary cause guarantees relapse. Allergic dermatitis — most commonly atopic dermatitis — is the most frequent primary cause of chronic and recurrent otitis externa.Journal of the…+2 More than 50% of dogs with atopic dermatitis exhibit otitis externa.BMC Veterinary… Food allergy is also a recognized primary cause, while flea allergy dermatitis is not associated with allergic otitis externa.AAHA Clinical G… Other primary causes to rule out include parasites, foreign body, neoplasia, endocrinopathy, and keratinization disorders.AAHA Clinical G…
Early dermatology collaboration produces substantially better outcomes than primary care management alone. The median time to otitis recurrence under collaborative board-certified veterinary dermatologist (BCVD) care is 171 days, compared to 21 days under primary care veterinarian management alone.Journal of the… The median number of recurrences drops from 4 under primary care to 2 with BCVD collaboration.Journal of the… Proliferative ear canal changes improve in 91% of cases under BCVD care versus 13% under primary care management.Journal of the… Referral or consultation is indicated for cases that are persistent or recur within 20–30 days over a 6-month period, with better outcomes when collaboration is initiated within 6 months of treatment.Journal of the…
Topical ozone therapy has emerged as a clinically effective alternative with a 100% treatment success rate by Otitis Index Score (OTIS-3) at 21 days, compared to 66.66% for a florfenicol-terbinafine-mometasone combination and 33.33% for ciprofloxacin drops alone.The Veterinary… Microbiological analysis confirmed complete elimination of bacterial growth in the ozone group, including eradication of multidrug-resistant Acinetobacter baumannii and Staphylococcus pseudintermedius.The Veterinary… Cytological improvement was significant in both the ozone group and the florfenicol-terbinafine-mometasone group.The Veterinary… The optimal dose and route of administration for ozone therapy remain undefined in the veterinary literature.The Veterinary…
A novel antibiotic-free topical formulation containing antimicrobial peptides and encapsulated plant extracts (chamomile, calendula, rosemary, and hops) achieved clinical efficacy in OTIS-3 and pruritus scores comparable to gentamicin-betamethasone-clotrimazole over four weeks, with significant cytological reduction in both groups.Pathogens This formulation was clinically effective in two of three dogs with multidrug-resistant bacterial infections and produced no adverse drug reactions, versus one adverse reaction in the conventional treatment group.Pathogens This represents a meaningful development for antimicrobial stewardship in the context of rising resistance.Pathogens
Maintenance ear cleaning frequency should decrease over time from daily to once or twice weekly as a preventive measure, rather than being discontinued after resolution of the acute episode.MSD Vet Manuals Owner compliance remains a recognized driver of treatment failure, and formulations requiring less frequent administration improve quality of life for both dogs and owners.BMC Veterinary…
| Advance | Protocol / Finding | Outcome | Key Caveat |
|---|---|---|---|
| Two-phase induction-maintenance | Ciprofloxacin-clotrimazole-betamethasone (stabilization) → topical HCA (90-day proactive phase) | Most dogs: no recurrence through observation period | Stabilization phase increased yeast occurrence |
| BCVD collaboration | Referral within 6 months of onset | Recurrence time 171 days vs. 21 days; 91% improvement in proliferative changes | Better outcomes when initiated within 6 months |
| Topical ozone therapy | Topical otic application × 21 days | 100% OTIS-3 success; complete bacterial elimination including MDR organisms | Optimal dose and route undefined |
| Antimicrobial peptide + plant extract formulation | Topical otic × 4 weeks | OTIS-3 and pruritus scores comparable to gentamicin-betamethasone-clotrimazole | Effective in 2/3 MDR cases; larger studies needed |
Would you like to go deeper on the proactive maintenance phase — specifically which dogs are candidates for long-term topical HCA and how to monitor for local or systemic glucocorticoid effects?